Search clinical trials for: 22-090

Total 5170 results

Impax Laboratories, LLC

Completed

A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).

Parkinson's Disease

United States, Canada, France, Germany, Poland, Romania, Spain, Ukraine
Sun Pharma Advanced Research Company Limited

Completed

Safety Study of SPARC1104

Spasticity

United States
Solvay Pharmaceuticals
Quintiles, Inc.

Terminated

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Congestive Heart Failure

United States, Argentina, Belgium, Czech Republic, Former Serbia and Montenegro, Germany, Poland, Russian Federation, South Africa, Spain
Seventh Medical Center of PLA General Hospital

Active, not recruiting

Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.

COVID-19

China
argenx

Active, not recruiting

An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis (ADAPT NXT)

Generalized Myasthenia Gravis

Georgia, United States, Austria, Belgium, Canada, France, Germany, Italy, Netherlands, Poland, Spain
Suzhou Connect Biopharmaceuticals, Ltd.

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD

Atopic Dermatitis

China
Solvay Pharmaceuticals

Completed

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Atrial Fibrillation | Atrial Flutter

Russian Federation, Romania, United States, Argentina, Czech Republic, Former Serbia and Montenegro, Germany, Israel, Poland, Slovakia, South Africa, Ukraine, United Kingdom
Solvay Pharmaceuticals

Terminated

The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women

Menopause

United States
University of Wisconsin, Madison

Recruiting

Brain Blood Flow Responses During Exercise: Younger Cohort

Magnetic Resonance Imaging | Cerebrovascular Circulation

United States
University of Wisconsin, Madison

Recruiting

Registry for CADASIL

Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy

United States
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging

Healthy | Carotid Artery Diseases

United States
Bioverativ, a Sanofi company

Active, not recruiting

Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A (XTEND-ed)

Hemophilia A

United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom
Gilead Sciences

Terminated

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) (REDPINE)

COVID-19

Spain, United States, United Kingdom, Portugal, Brazil, South Africa
Preben Kjolhede, MD, professor
Linkoeping University; Ostergotland County Council, Sweden; Medical Research... and other collaborators

Completed

Lymphedema After Primary Surgery for Endometrial Cancer (LASEC)

Hysterectomy | Lymphadenectomy | Carcinoma of the Endometrium

Sweden
University of Wisconsin, Madison
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

Brain Blood Flow Responses During Exercise

Magnetic Resonance Imaging | Cerebrovascular Circulation

United States
Auckland City Hospital

Recruiting

MAnagement of Systolic Blood Pressure During Thrombectomy by Endovascular Route for Acute Ischaemic STROKE (MASTERSTROKE)

Stroke | Blood Pressure | Embolus Cerebral

New Zealand
TILT Biotherapeutics Ltd.
Merck Sharp & Dohme LLC

Recruiting

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA)

Platinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditions

United States, Finland
University of Wisconsin, Madison
Radboud University Medical Center; University of Toronto; Explore DEEP Inc

Recruiting

Virtual-reality and Emotion Regulation in Violence-Exposed Youth (VERVE)

Emotional Regulation | Adolescent Behavior

United States
Celgene
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...

Recruiting

Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Beta-Thalassemia

United States, Turkey, Italy, Thailand, Germany, Greece, China, India, Lebanon
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)

Metastatic Colorectal Cancer

Canada, Hungary, United States, Australia, Belgium, Chile, Colombia, France, Germany, Japan, Korea, Republic of, Latvia, Lithuania, Russian Federation, South Africa, Spain, Turkey, Ukraine
University of Wisconsin, Madison
Boston Medical Center

Active, not recruiting

Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | Herpes Zoster

United States
University of Bristol

Completed

Alcohol Detoxification in Primary Care Treatment (ADEPT) (ADEPT)

Alcoholism

United Kingdom
Sun Pharmaceutical Industries Limited

Active, not recruiting

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Active Psoriatic Arthritis

United States, Australia, Czechia, Germany, India, Japan, Korea, Republic of, Poland, Spain
UCB Pharma SA
Parexel

Completed

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Rheumatoid Arthritis

Romania, United States, Australia, Austria, Bulgaria, Canada, Czechia, France, Germany, Greece, Hungary, Ireland, Italy, Mexico, Monaco, Poland, Portugal, Spain, Switzerland, United Kingdom
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).

Osteoarthritis

United States
Boehringer Ingelheim

Completed

Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data

HIV Infections

Germany
Boehringer Ingelheim

Completed

Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS

Restless Legs Syndrome

Korea, Republic of
University of Wisconsin, Madison
American Heart Association

Recruiting

A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

Stroke

United States
Celgene
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...

Active, not recruiting

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve (COMMANDS)

Myelodysplastic Syndromes

United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Switzerland, Taiwan, Turke... and more
Arcutis Biotherapeutics, Inc.

Completed

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Seborrheic Dermatitis

United States
argenx

Active, not recruiting

Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis (ADAPTSC+)

Generalized Myasthenia Gravis

United States, Belgium, Czechia, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Spain
CinCor Pharma, Inc.

Completed

A Study of CIN-107 in Patients With Uncontrolled Hypertension (HALO)

Uncontrolled Hypertension

United States
argenx

Completed

Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis (ADAPTsc)

Generalized Myasthenia Gravis

Spain, United States, Belgium, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation
argenx

Completed

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness (ADAPT)

Generalized Myasthenia Gravis

United States, Belgium, Canada, Czechia, Denmark, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Serbia, United Kingdom
Universidad Complutense de Madrid
NORICUM SL

Recruiting

Regeneration of Alveolar Sockets With rhBMP-2-loaded Bovine Bone Mineral (PROTEOGRAFT)

Edentulous Alveolar Ridge | Alveolar Bone Loss | Loss of Teeth Due to Extraction

Spain
University of Wisconsin, Madison
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

Stroke Rehabilitation Using Brain-Computer Interface (BCI) Technology

Stroke

United States
University of Wisconsin, Madison
Novartis Pharmaceuticals

Completed

Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy

Idiopathic Angioedema

United States
Merck Sharp & Dohme LLC

Recruiting

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

Melanoma | Renal Cell Carcinoma | Non-Small Cell Lung Cancer

Poland, United States, Argentina, Chile, Japan, Australia, France, New Zealand, South Africa, Turkey
Academisch Medisch Centrum - Universiteit van Amsterdam...
Ambulance Amsterdam; Stichting ZiektekostenVerzekering Krijgsmacht

Recruiting

Fentanyl OR Esketamine for Traumatic PAIN (FORE-PAIN) Trial (FORE-PAIN)

Analgesia | Emergency Medical Services | Acute Pain Due to Trauma | Fentanyl | Esketamine

Netherlands
Merck Sharp & Dohme LLC

Completed

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

Prostatic Neoplasms

United States, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
University of Wisconsin, Madison
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies (UW17104)

Renal Cell Carcinoma

United States
Centre Antoine Lacassagne

Completed

Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer

Head and Neck Cancer

France
University of Wisconsin, Madison
Radius Health, Inc.

Active, not recruiting

Abaloparatide Before Total Knee Arthroplasty

Osteoporosis | Arthroplasties, Knee Replacement

United States
University of Wisconsin, Madison
Gordon and Betty Moore Foundation

Completed

Community Acquired Pneumonia in Older Adults

Pneumonia | Aspiration Pneumonia

United States
Rennes University Hospital

Completed

Pregnancy Environment and Newborn Malformations (PENEW)

Congenital Malformation

France
Institut Bergonié

Completed

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (OMEGA)

Colorectal Cancer

France
Novo Nordisk A/S

Completed

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin (LIRA-SWITCH™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Israel, Canada, Hungary, India, Spain, Puerto Rico
Cancer Trials Ireland

Completed

Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

Ireland
Ludwig Boltzmann Gesellschaft

Completed

Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone (GH-003)

Elderly

Austria
Sigrid Therapeutics AB

Recruiting

Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® (SHINE)

Overweight or Obesity

Slovakia, Poland, Romania

Search clinical trials for: 22-090

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations